SHIRE PLC SHPG Income Statement

Shire plc (SHPG)

Income statement / TTM

Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Sep'08	Jun'08
Revenues:
Total revenues
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales
-	14,890	14,673	-	-	13,940	12,670	10,885	8,888	7,149	6,304	6,099	5,976	5,952	5,945	5,830	5,610	5,229	4,967	4,757	4,420	4,304	4,244	4,252	4,253	4,216	4,062	3,844	3,752	3,528	3,299	3,128	3,053	2,861	2,655	2,693	2,629	2,732	0	0	0
Royalties and other revenues
-	637	680	-	-	635	588	510	420	361	336	316	312	274	222	191	165	163	170	176	199	203	223	241	238	259	266	283	273	287	306	328	369	353	337	292	238	243	0	0	0
Other revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	35	35	31	32	25	26	29	29	26	25	21	14	10	11	13	21	25	26	0	0	0
Total revenues
-	15,527	15,354	-	-	14,576	13,259	11,396	9,306	7,509	6,637	6,416	6,277	6,219	6,163	6,022	5,772	5,387	5,137	4,934	4,655	4,543	4,499	4,527	4,516	4,502	4,357	4,158	4,052	3,840	3,627	3,471	3,433	3,225	3,006	3,007	2,893	3,001	0	0	0
Costs and expenses:
Cost of sales
4,661	4,505	4,506	4,700	4,490	5,225	4,894	3,816	3,013	1,539	989	969	937	928	977	979	939	865	752	670	599	586	574	585	595	594	585	551	564	510	486	463	436	429	406	388	369	407	0	0	0
Research and development
1,678	1,674	1,789	1,763	1,741	1,849	1,602	1,439	1,376	1,106	1,587	1,564	1,452	1,439	900	1,067	1,056	1,053	1,073	933	972	971	953	953	891	868	806	764	741	738	708	661	623	573	585	639	612	601	0	0	0
Selling, general and administrative
3,432	3,455	3,446	3,530	3,637	3,653	3,429	3,015	2,423	1,990	1,810	1,842	1,777	1,858	1,858	1,782	1,750	1,624	1,537	1,499	1,697	1,738	1,839	1,948	1,828	1,843	1,772	1,675	1,714	1,655	1,569	1,526	1,475	1,403	1,383	1,342	1,301	1,418	0	0	0
Amortization of acquired intangible assets
1,863	1,911	1,888	1,768	1,751	1,623	1,402	1,173	835	611	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
In-process R&D ("IPR&D") charge
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Gain on sale of product rights
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Integration and acquisition costs
709	853	1,018	894	842	889	908	883	825	630	55	39	-43	-96	227	158	-18	-36	-131	-134	38	22	12	13	7	9	11	0	9	10	1	8	7	7	9	10	17	11	0	0	0
Reorganization costs
292	42	47	47	30	126	123	121	154	83	86	97	117	114	146	180	164	148	120	88	47	35	17	0	6	11	18	24	29	33	34	34	28	21	15	12	7	5	0	0	0
Goodwill impairment charge
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	198	7	7	7	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain)/loss on sale of Oncology and product rights
267	-0	-5	0	4	10	17	16	13	8	13	14	15	60	57	88	87	45	45	15	49	39	31	18	-18	-13	-11	-6	8	8	15	16	10	0	0	-	0	-	-	0	-
Total operating expenses
12,371	12,444	12,701	12,705	12,488	13,357	12,343	10,433	8,715	6,056	5,148	4,997	4,732	4,558	4,298	4,324	3,956	3,761	3,458	3,200	3,345	3,343	3,387	3,482	3,315	3,319	3,193	3,022	3,051	2,938	2,784	2,677	2,567	2,423	2,393	2,387	2,417	2,685	0	0	0
Operating income from continuing operations
3,330	3,083	2,652	2,455	2,333	1,219	916	962	590	1,452	1,488	1,419	1,544	1,660	1,865	1,698	1,815	1,626	1,678	1,733	1,309	1,200	1,111	1,045	1,201	1,183	1,164	1,135	1,001	901	842	794	865	801	612	620	475	316	0	0	0
Interest income
8	9	9	9	12	20	20	18	12	4	3	4	5	8	26	24	23	20	1	2	2	2	2	3	2	2	2	1	2	2	2	2	2	1	1	1	5	11	0	0	0
Interest expense
531	548	563	578	576	621	567	469	328	152	76	41	36	32	32	30	36	38	36	38	36	36	37	38	39	39	40	39	38	36	35	35	34	36	37	39	123	130	0	0	0
Other (expense)/income, net
-43	52	26	7	-2	-16	-12	-25	-24	-1	-9	3	6	3	8	8	12	6	1	-3	-7	-4	-5	-2	6	18	20	18	14	0	-2	7	7	13	21	60	10	3	0	0	0
Total other expense, net
-566	-486	-528	-561	-566	-617	-559	-476	-340	-149	-82	-33	1,610	1,613	1,637	1,638	0	0	0	-	0	0	0	-	-30	-19	-17	-18	-21	-34	-35	-24	-24	-20	-14	22	-108	-115	0	0	0
Income from continuing operations before income taxes and equity in earnings of equity method investees
2,764	2,596	2,124	1,893	1,767	601	356	486	250	1,302	1,406	1,385	3,154	3,274	3,503	3,336	1,814	1,613	1,645	1,693	1,268	1,161	1,072	1,007	1,170	1,163	1,146	1,117	979	867	807	769	841	781	597	643	367	200	0	0	0
Income taxes
-2,031	-2,221	-2,321	-2,357	136	-106	-201	-126	-163	44	70	46	111	195	62	56	-22	-9	257	277	293	262	224	203	194	222	238	236	209	192	177	182	242	220	142	138	75	45	0	0	0
Equity in earnings/(losses) of equity method investees, net of taxes
13	5	4	2	-6	-4	-9	-8	-2	-2	-1	-2	-2	-0	2	2	7	5	2	3	1	1	0	1	-0	0	2	2	4	3	3	1	-1	-0	-1	-0	2	0	0	0	0
Income from continuing operations, net of taxes
4,809	4,823	4,449	4,253	1,623	703	548	603	411	1,256	1,334	1,337	3,039	3,078	3,442	3,282	1,843	1,629	1,391	1,419	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	503	294	155	0	0	0
(Loss)/gain from discontinued operations, net of taxes
-0	-1	-2	18	0	-17	-265	-276	-260	-266	-22	-34	155	143	142	122	-546	-533	-561	-754	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-12	-13	-13	0	0	0
Add: Net loss attributable to the noncontrolling interest in subsidiaries
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-1	-1	0	0	0
Net income
4,808	4,822	4,447	4,271	1,623	685	283	327	150	990	1,312	1,303	3,195	3,222	3,585	3,405	1,297	1,095	830	665	643	592	571	745	958	924	892	865	706	673	0	-	0	0	-	491	282	143	0	0	0
Earnings per Ordinary Share basic
Earnings from continuing operations (in usd per share)
0.59	0.67	0.61	3.42	0.61	0.27	0.39	0.38	-0.41	0.12	0.69	0.48	0.81	0.28	0.70	3.38	0.87	0.90	0.43	0.98	0.54	0.52	0.51	-	-	-	-	-	-	-	-	-	-	-	-	0.32	0.11	0.10	0.40	-0.06	-0.14
Earnings from discontinued operations (in usd per share)
0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.01	-0.02	-0.36	0.02	-0.01	-0.04	-0.01	0.00	0.31	-0.06	-0.00	-0.03	-0.87	-0.04	-0.06	-0.39	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	-0.01	-0.00	-0.00	0.00
Earnings per Ordinary Share - basic (in usd per share)
0.59	0.67	0.61	3.42	0.61	0.27	0.41	0.39	-0.43	-0.24	0.71	0.47	0.77	0.27	0.70	3.70	0.81	0.89	0.39	0.11	0.50	0.46	0.11	0.07	0.40	0.42	0.43	0.46	0.35	0.37	0.38	0.30	0.17	0.29	0.30	0.32	0.11	0.08	0.39	-0.06	-0.14
Earnings per Ordinary Share diluted
Earnings from continuing operations (in usd per share)
0.58	0.67	0.60	3.41	0.60	0.26	0.39	0.37	-0.41	0.12	0.69	0.49	0.80	0.28	0.69	3.35	0.87	0.89	0.43	0.92	0.52	0.50	0.49	-	-	-	-	-	-	-	-	-	-	-	-	0.32	0.10	0.09	0.38	-0.06	-0.14
Earnings from discontinued operations (in usd per share)
0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.01	-0.02	-0.36	0.02	-0.01	-0.04	-0.01	0.00	0.31	-0.06	-0.00	-0.03	-0.81	-0.03	-0.05	-0.36	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-0.00	-0.01	-0.00	-0.00	0.00
Earnings per Ordinary Share - diluted (in usd per share)
0.58	0.67	0.60	3.41	0.60	0.26	0.41	0.38	-0.43	-0.24	0.71	0.48	0.76	0.27	0.69	3.67	0.80	0.88	0.39	0.11	0.48	0.45	0.12	0.08	0.39	0.41	0.41	0.44	0.33	0.35	0.37	0.29	0.17	0.28	0.29	0.32	0.10	0.08	0.38	-0.06	-0.14
Cash dividends declared per ordinary share (in USD per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash dividends paid per ordinary share (in USD per share)
-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of shares:
Basic (in shares)
914	912	909	908	907	906	904	905	900	682	591	591	590	590	589	588	587	586	584	558	548	549	551	555	555	557	553	551	551	552	549	547	547	546	543	543	540	539	539	540	542
Diluted (in shares)
921	917	912	911	911	912	911	928	900	682	593	593	593	593	592	593	592	590	588	600	585	586	588	590	593	594	595	599	593	595	593	628	556	590	586	523	548	543	577	540	542
Income from continuing operations, net of taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	504	295	157	0	0	0
Loss from discontinued operations, net of taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12	-13	-13	0	0	0
Numerator for basic earnings per share
4,808	4,822	4,447	4,271	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	-	491	282	143	0	0	0
Amortization Cost Of Product Sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-
Amortization and impairment charges recorded to selling general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-